Padma Vibhushan for Ambani, Shri Shri, Rajini; Bhushan for Anupam Kher, Sania

Mangaluru, July 1: The district administration has imposed prohibitory orders under Section 144 in entire Dakshina Kannada between 8pm and 5am in the entire month of July.

Notice in this regard was issued today by Deputy Commissioner Sindhu B Roopesh. The order will come into force with immediate and will be in place ill July 31, the DC said.

The decision was taken days after Karnataka government took steps to tighten covid restriction and imposed lockdown from 8pm to 5am. 

Under the imposed Section 144, the presence or movement of one or more persons in public places are prohibited. Besides, the gathering of any sort anywhere, including religious places subject to certain conditions in view of the COVID-19 pandemic will also be restricted. 
 

Bengaluru, Feb 17: Days after 10 MLAs were inducted in the Cabinet, Chief Minister B S Yediyurappa is likely to expand his Cabinet again as some BJP MLAs are unhappy, said BJP sources.

Several leaders including Umesh Katti, CP Yogeshwar, Raju Gowda and MP Renukacharya are miffed over the recent cabinet expansion, claim sources.

On February 6, ST Somashekar, Ramesh Laxmanrao Jarkiholi, Anand Singh, K Sudhakar, BA (Byrathi) Basavaraj, Arabail Hebbar Shivaram, Hasavanagowda C Patil, K Gopalaiah, Narayana Gowda and Shrimant Balasaheb Patil took oath as ministers.

It should be noted that many MLAs had won the by-polls on a Bharatiya Janata Party (BJP) ticket in December last year after switching loyalties from the Janata Dal (Secular) (JDS) and Congress.

In the December 5 by-polls held in 15 Assembly constituencies, the BJP had won 12, while Congress managed to bag only two. One seat was won by an Independent candidate while the JDS drew a blank.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.